Yanli Wang

1.6k total citations
92 papers, 1.0k citations indexed

About

Yanli Wang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Yanli Wang has authored 92 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 17 papers in Surgery and 17 papers in Epidemiology. Recurrent topics in Yanli Wang's work include Nutritional Studies and Diet (6 papers), Alzheimer's disease research and treatments (6 papers) and Dementia and Cognitive Impairment Research (6 papers). Yanli Wang is often cited by papers focused on Nutritional Studies and Diet (6 papers), Alzheimer's disease research and treatments (6 papers) and Dementia and Cognitive Impairment Research (6 papers). Yanli Wang collaborates with scholars based in China, United States and Canada. Yanli Wang's co-authors include Lisa M. Bellini, Orit Even‐Shoshan, Kevin G. Volpp, Amy K. Rosen, Jeffrey H. Silber, Patrick S. Romano, Tiffany Behringer, Paul R. Rosenbaum, Jiwei Jiang and Feifei Chong and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Circulation.

In The Last Decade

Yanli Wang

86 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Wang China 17 231 137 136 135 115 92 1.0k
Nikolaos Samaras Switzerland 14 332 1.4× 277 2.0× 167 1.2× 119 0.9× 77 0.7× 33 1.1k
Hung-Jung Lin Taiwan 20 313 1.4× 148 1.1× 148 1.1× 302 2.2× 58 0.5× 52 1.2k
Ahmet Baydın Türkiye 17 238 1.0× 154 1.1× 127 0.9× 249 1.8× 30 0.3× 92 1.0k
José Mauro Vieira Brazil 17 91 0.4× 160 1.2× 114 0.8× 141 1.0× 59 0.5× 45 1.2k
Noriko Sasaki Japan 21 45 0.2× 174 1.3× 123 0.9× 81 0.6× 60 0.5× 103 1.3k
Saurabh Gupta United States 19 91 0.4× 293 2.1× 183 1.3× 282 2.1× 66 0.6× 69 1.0k
J Bryant United Kingdom 20 74 0.3× 95 0.7× 79 0.6× 244 1.8× 131 1.1× 32 1.4k
Jingli Chen China 14 166 0.7× 260 1.9× 73 0.5× 281 2.1× 46 0.4× 54 1.5k
Badri Man Shrestha United Kingdom 17 42 0.2× 140 1.0× 105 0.8× 302 2.2× 44 0.4× 56 1.0k
Michael S. Nussbaum United States 23 111 0.5× 254 1.9× 88 0.6× 698 5.2× 138 1.2× 77 1.4k

Countries citing papers authored by Yanli Wang

Since Specialization
Citations

This map shows the geographic impact of Yanli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Wang more than expected).

Fields of papers citing papers by Yanli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Wang. The network helps show where Yanli Wang may publish in the future.

Co-authorship network of co-authors of Yanli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Wang. A scholar is included among the top collaborators of Yanli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Wang. Yanli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Strober, Bruce, Laura C. Coates, Mark Lebwohl, et al.. (2023). Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis. Drug Safety. 47(1). 39–57. 31 indexed citations
4.
Wang, Yanli, et al.. (2023). Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 49(1). 80–80. 7 indexed citations
5.
Xiao, Chenwen, Lin Li, Yan Liu, et al.. (2022). Inhibitory Effect and Mechanism of Trichoderma taxi and Its Metabolite on Trichophyton mentagrophyte. Journal of Fungi. 8(10). 1006–1006.
6.
Wang, Yanli, Yuan Zhang, & Jun Xu. (2022). Sodium oligomannate combined with rivastigmine may improve cerebral blood flow and cognitive impairment following CAR-T cell therapy: A case report. Frontiers in Oncology. 12. 902301–902301. 4 indexed citations
7.
Zhang, Yu, Yanli Wang, Shuqin Wang, et al.. (2022). Qualitative Research on the Training Experiences and Needs of Intensive Care Unit General Nurses Against the Background of Regular Coronavirus Disease 2019 Prevention and Control. Frontiers in Public Health. 10. 919987–919987. 2 indexed citations
8.
Li, Ying, Peng Li, Guangwen Liu, et al.. (2022). Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states. Frontiers in Pharmacology. 13. 1012294–1012294. 4 indexed citations
9.
Wang, Yujie, Qian Lü, Lichuan Zhang, et al.. (2020). Nutrition Impact Symptom Clusters in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy. Journal of Pain and Symptom Management. 62(2). 277–285. 18 indexed citations
10.
Yu, Min, Ping Liu, Mingxia Yang, et al.. (2020). <p>Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition</p>. Drug Design Development and Therapy. Volume 14. 1191–1202. 20 indexed citations
12.
Xie, Guoxiang, Xiaocheng Li, Di Jin, et al.. (2019). [Prevalence and epidemic characteristics of metabolic syndrome among adult residents in Nanjing City in 2010-2013].. PubMed. 48(1). 61–75. 1 indexed citations
13.
Orange, Jordan S., Jason Roy, Yanli Wang, et al.. (2015). Validity of Primary Immunodeficiency Disease Diagnoses in United States Medicaid Data. Journal of Clinical Immunology. 35(6). 566–572. 6 indexed citations
14.
Wang, Yanli, et al.. (2014). Noncanonical Gβ Gib2 Is a Scaffolding Protein Promoting cAMP Signaling through Functions of Ras1 and Cac1 Proteins in Cryptococcus neoformans. Journal of Biological Chemistry. 289(18). 12202–12216. 18 indexed citations
15.
Wang, Lina, Shiyuan Zhou, Jiping Zhou, et al.. (2013). Relationship between 5, 10-methylenetetrahydrofolate gene polymorphism and congenital heart disease in nuclear family. Zhonghua shiyong erke linchuang zazhi. 28(1). 32–35. 3 indexed citations
16.
Zheng, Heming, et al.. (2013). Current status of iodine deficiency disorders in Henan Province in 2011. Chin J Endemiol. 32(5). 526–528. 1 indexed citations
17.
Ge, Xiaoxiao, et al.. (2013). Primary squamous cell carcinoma of the esophagus initially presenting as a large retroperitoneal mass: A case diagnosed as cancer of unknown primary site. Molecular and Clinical Oncology. 1(3). 503–506. 2 indexed citations
18.
Jiao, Dechao, Xinwei Han, Ya-Feng Wang, et al.. (2012). Microwave Ablation Treatment of Liver Cancer with a 2,450-MHz Cooled-shaft Antenna: Pilot Study on Safety and Efficacy. Asian Pacific Journal of Cancer Prevention. 13(2). 737–742. 17 indexed citations
19.
20.
Fang, Yu, et al.. (2011). Nutritional risk and nutritional support in gastrointestinal cancer surgical patients. 19(6). 368–371. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026